VSV Oncolytic Virotherapy in the B16 Model Depends Upon Intact MyD88 Signaling

We show here, for the first time to our knowledge, that the antitumor therapy of oncolytic vesicular stomatitis virus (VSV) in the B16ova model depends upon signaling through myeloid differentiation primary response gene 88 (MyD88) in host cells. VSV-mediated therapy of B16ova tumors was abolished i...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Wongthida, Phonphimon, Diaz, Rosa M, Galivo, Feorillo, Kottke, Timothy, Thompson, Jill, Melcher, Alan, Vile, Richard
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2011
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3017452/
https://ncbi.nlm.nih.gov/pubmed/20959810
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2010.225
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak